Table 3.

Identification results of nitroslated peptides.

No.	Sequence	Length	Missed cleavages	Mass	Start and end position		Control			NaNO2
							0d	3d	7d	0d	3d	7d
1	ALELFRNDMAAQYK	14	1	1668.83	135	148	√	√	√	√	√	√
2	ALELFRNDMAAQYKVLGFHG	20	2	2279.15	135	154	√		√	√	#	#
3	ASEDLKK	7	1	789.42	58	64		#			√	#
4	ASEDLKKHGNTVLTALGGILK	21	2	2164.22	58	78			√
5	FKHLKTEAEMK	11	2	1360.72	47	57	√	√	#	√		√
6	GHHEAEVK	8	0	905.44	81	88	√		√	√	√
7	GHHEAEVKHLAESHANK	17	1	1892.92	81	97	√	√	√	√
8	GHHEAEVKHLAESHANKHK	19	2	2158.08	81	99	√			√	√
9	GLSDGEWQLVLNAWGK	16	0	1771.89	2	17	√	√	√	√	√	√
10	GLSDGEWQLVLNAWGKVEADVAGHGQEVLIR	31	1	3345.71	2	32		√	√		#	#
11	HGNTVLTALGGILK	14	0	1392.81	65	78	√	√	√	√	√	√
12	HGNTVLTALGGILKK	15	1	1520.90	65	79	√	√	√	√	√	√
13	HLAESHANK	9	0	1005.50	89	97	√	#	√	√	√	#
14	HLAESHANKHK	11	1	1270.65	89	99	#	√		#	√	√
15	HLAESHANKHKIPVK	15	2	1707.95	89	103	√	√	√	√	√	√
16	HLKTEAEMK	9	1	1085.55	49	57	#	√	#	#		√
17	HLKTEAEMKASEDLK	15	2	1728.87	49	63		√			√	√
18	HPSDFGADAQAAMSK	15	0	1531.67	120	134	√	√	√	√	√	√
19	HPSDFGADAQAAMSKALELFR	21	1	2261.09	120	140	√	√	√	√	√	#
20	IPVKYLEFISDAIIHVLHAK	20	1	2305.32	100	119	√		#	√
21	KGHHEAEVK	9	1	1033.53	80	88	#	√	√	#		√
22	KGHHEAEVKHLAESHANK	18	2	2021.02	80	97		√	√
23	KHGNTVLTALGGILK	15	1	1520.90	64	78	√	√	√	√	√	√
24	LFTGHPETLEK	11	0	1270.66	33	43	√	√	√	√	√	√
25	LFTGHPETLEKFDK	14	1	1660.85	33	46	√	√	√	√	√	√
26	LFTGHPETLEKFDKFK	16	2	1936.01	33	48	√	√	√	√	√	√
27	NDMAAQYK	8	0	939.41	141	148	√	√	√	√	√	√
28	NDMAAQYKVLGFHG	14	1	1549.73	141	154	√	√	√	√	√	√
29	TEAEMKASEDLK	12	1	1350.63	52	63	#	√	√	#		√
30	TEAEMKASEDLKK	13	2	1478.73	52	64	√	√	√	√	√	√
31	VEADVAGHGQEVLIR	15	0	1591.83	18	32	√	√	√	√	√	√
32	VEADVAGHGQEVLIRLFTGHPETLEK	26	1	2844.48	18	43		√	#
33	YLEFISDAIIHVLHAK	16	0	1868.02	104	119	√	√	√	√	√	√
34	YLEFISDAIIHVLHAKHPSDFGADAQAAMSK	31	1	3381.68	104	134	√	√	√	√

注: √: By MS/MS; #: By matching.